{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:42:59Z","timestamp":1792615379826,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006419","name":"EuroQol Research Foundation","doi-asserted-by":"publisher","award":["59-VS"],"award-info":[{"award-number":["59-VS"]}],"id":[{"id":"10.13039\/501100006419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vhri.2026.102138","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:28:29Z","timestamp":1792524509000},"page":"102138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Valuing Health States: An EQ-5D-5L Value Set for Uzbekistan"],"prefix":"10.1016","author":[{"given":"Nilufar","family":"Abduvalieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakhrom","family":"Mirkasimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufar","family":"Rashitova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Roudijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanni","family":"Rencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilfuza","family":"Djalalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vhri.2026.102138_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"issue":"2","key":"10.1016\/j.vhri.2026.102138_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","article-title":"EQ-5D and the EuroQol Group: past, present and future","volume":"15","author":"Devlin","year":"2017","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"10.1016\/j.vhri.2026.102138_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"10","key":"10.1016\/j.vhri.2026.102138_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2026.102138_bib7","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s10198-013-0503-2","article-title":"Introducing the composite time trade-off: a test of feasibility and face validity","volume":"14","author":"Janssen","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"6","key":"10.1016\/j.vhri.2026.102138_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40273-018-0623-8","article-title":"Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries","volume":"36","author":"Janssen","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.vhri.2026.102138_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"issue":"6","key":"10.1016\/j.vhri.2026.102138_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s40258-025-00989-2","article-title":"Measuring and valuing health using EuroQol instruments: new developments 2025 and beyond","volume":"23","author":"Devlin","year":"2025","journal-title":"Appl Health Econ Health Policy"},{"issue":"11","key":"10.1016\/j.vhri.2026.102138_bib11","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s11136-016-1375-6","article-title":"EQ-5D in Central and Eastern Europe: 2000-2015","volume":"25","author":"Rencz","year":"2016","journal-title":"Qual Life Res"},{"issue":"8","key":"10.1016\/j.vhri.2026.102138_bib12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","article-title":"Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines","volume":"21","author":"Kennedy-Martin","year":"2020","journal-title":"Eur J Health Econ"},{"issue":"8","key":"10.1016\/j.vhri.2026.102138_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40273-015-0292-9","article-title":"A checklist for reporting valuation studies of multi-attribute utility-based instruments (CREATE)","volume":"33","author":"Xie","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.vhri.2026.102138_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jval.2018.05.010","article-title":"Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol","volume":"22","author":"Stolk","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2026.102138_bib16","author":"Oppe"},{"key":"10.1016\/j.vhri.2026.102138_bib17","series-title":"Value Sets for EQ-5D-5L","first-page":"29","article-title":"Experimental design for the valuation of the EQ-5D-5L","author":"Oppe","year":"2022"},{"issue":"1","key":"10.1016\/j.vhri.2026.102138_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12955-024-02266-7","article-title":"The EQ-5D-5L valuation study for Trinidad and Tobago","volume":"22","author":"Bailey","year":"2024","journal-title":"Health Qual Life Outcomes"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2026.102138_bib19","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s10198-013-0511-2","article-title":"Dealing with the health state \u201cdead\u201d when using discrete choice experiments to obtain values for EQ-5D-5L heath states","volume":"14","author":"Ramos-Go\u00f1i","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"11","key":"10.1016\/j.vhri.2026.102138_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/MLR.0000000000000178","article-title":"Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values","volume":"52","author":"Krabbe","year":"2014","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.vhri.2026.102138_bib21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10198-016-0841-y","article-title":"Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale","volume":"18","author":"Krabbe","year":"2016","journal-title":"Eur J Health Econ"},{"issue":"10","key":"10.1016\/j.vhri.2026.102138_bib22","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jval.2024.05.024","article-title":"A new and improved experimental design for the discrete choice experiment module of the EuroQol valuation technology protocol","volume":"27","author":"Jonker","year":"2024","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2026.102138_bib23","series-title":"Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide","author":"Devlin","year":"2022"},{"issue":"3","key":"10.1016\/j.vhri.2026.102138_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263816","article-title":"First population norms for the EQ-5D-3L in the Russian Federation","volume":"17","author":"Khabibullina","year":"2022","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.vhri.2026.102138_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jval.2016.10.012","article-title":"Quality control process for EQ-5D-5L valuation studies","volume":"20","author":"Ramos-Go\u00f1i","year":"2017","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.vhri.2026.102138_bib27","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/MLR.0000000000000283","article-title":"Valuation and modeling of EQ-5D-5L health states using a hybrid approach","volume":"55","author":"Ramos-Go\u00f1i","year":"2017","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.vhri.2026.102138_bib28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","article-title":"United States valuation of EQ-5D-5L health states using an international protocol","volume":"22","author":"Pickard","year":"2019","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.vhri.2026.102138_bib29","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jval.2020.03.019","article-title":"Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary","volume":"23","author":"Rencz","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2026.102138_bib30","first-page":"1","article-title":"Combining continuous and dichotomous responses in a hybrid model. ResearchGate","author":"Ramos-Go\u00f1i","year":"2016","journal-title":"EuroQol Working Paper Series"},{"issue":"3","key":"10.1016\/j.vhri.2026.102138_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11482-015-9389-8","article-title":"An Islamic perspective on coping with life stressors","volume":"11","author":"Achour","year":"2015","journal-title":"Appl Res Qual Life"},{"issue":"1","key":"10.1016\/j.vhri.2026.102138_bib32","first-page":"5485","article-title":"Resilience and patience (sabr) in Islamic view when observing the movement control (order MCO) during the Covid 19 pandemic","volume":"24","author":"Salleh","year":"2020","journal-title":"Int J Psychosoc Rehabil"},{"issue":"10","key":"10.1016\/j.vhri.2026.102138_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016969","article-title":"The effect of religion on the perception of health states among adults in the United Arab Emirates: a qualitative study","volume":"7","author":"Elbarazi","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.vhri.2026.102138_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12955-018-0985-9","article-title":"Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values","volume":"16","author":"Barry","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.vhri.2026.102138_bib35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/jid.3693","article-title":"Barriers to disability-inclusive employment in Uzbekistan: a pilot qualitative study of disabled people\u2019s lived experiences","volume":"34","author":"Yusupov","year":"2022","journal-title":"J Int Dev"},{"key":"10.1016\/j.vhri.2026.102138_bib36","series-title":"Overcoming barriers to achieving inclusive university objectives in Uzbekistan","author":"Robertson","year":"2026"},{"key":"10.1016\/j.vhri.2026.102138_bib38","series-title":"Uzbekistan: Country Profile on Disability Inclusion","year":"2021"},{"issue":"6","key":"10.1016\/j.vhri.2026.102138_bib39","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/fampra\/cmx034","article-title":"Adverse impacts of chronic pain on health-related quality of life, work productivity, depression and anxiety in a community-based study","volume":"34","author":"Kawai","year":"2017","journal-title":"Fam Pract"},{"key":"10.1016\/j.vhri.2026.102138_bib40","first-page":"94","article-title":"Geriatric care in traditional communities of Central Asia","volume":"52","author":"Martynenko","year":"2025","journal-title":"Pan Afr Med J"},{"issue":"4","key":"10.1016\/j.vhri.2026.102138_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40273-021-01100-y","article-title":"The EQ-5D-5L valuation study in Egypt","volume":"40","author":"Al Shabasy","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.vhri.2026.102138_bib42","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s11136-023-03378-1","article-title":"A national survey of Iranian general population to estimate a value set for the EQ-5D-5L","volume":"32","author":"Afshari","year":"2023","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.vhri.2026.102138_bib43","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","article-title":"Estimating an EQ-5D-5L value set for China","volume":"20","author":"Luo","year":"2017","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.vhri.2026.102138_bib44","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s11136-020-02469-7","article-title":"An EQ-5D-5L value set for Vietnam","volume":"29","author":"Mai","year":"2020","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.vhri.2026.102138_bib45","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s11136-015-1205-2","article-title":"The EQ-5D-5L valuation study in Korea","volume":"25","author":"Kim","year":"2016","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.vhri.2026.102138_bib46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jval.2024.01.017","article-title":"Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: a national representative study","volume":"27","author":"Al-Jedai","year":"2024","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.vhri.2026.102138_bib47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jval.2021.11.1370","article-title":"Development of an EQ-5D value set for India using an extended design (DEVINE) study: the Indian 5-level version EQ-5D value set","volume":"25","author":"Jyani","year":"2022","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.vhri.2026.102138_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209344","article-title":"Valuation of the EQ-5D-5L in Taiwan","volume":"13","author":"Lin","year":"2018","journal-title":"PLOS One"},{"issue":"11","key":"10.1016\/j.vhri.2026.102138_bib49","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40273-017-0538-9","article-title":"The Indonesian EQ-5D-5L value set","volume":"35","author":"Purba","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vhri.2026.102138_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vhri.2019.08.475","article-title":"Valuing health state: an EQ-5D-5L value set for Ethiopians","volume":"22","author":"Welie","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"6","key":"10.1016\/j.vhri.2026.102138_bib51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","article-title":"German value set for the EQ-5D-5L","volume":"36","author":"Ludwig","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.vhri.2026.102138_bib52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s41669-022-00353-3","article-title":"An EQ-5D-5L value set for Belgium","volume":"6","author":"Bouckaert","year":"2022","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.vhri.2026.102138_bib53","series-title":"Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide [Internet]","author":"Devlin","year":"2022"},{"issue":"8","key":"10.1016\/j.vhri.2026.102138_bib54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11136-010-9678-5","article-title":"Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets","volume":"19","author":"Bailey","year":"2010","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.vhri.2026.102138_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bioe.13109","article-title":"The balancing of virtues-Muslim perspectives on palliative and end of life care: empirical research analysing the perspectives of service users and providers","volume":"37","author":"Suleman","year":"2023","journal-title":"Bioethics"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926005534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926005534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:57:49Z","timestamp":1792612669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926005534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S2212109926005534"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.102138","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valuing Health States: An EQ-5D-5L Value Set for Uzbekistan","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.102138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"102138"}}